Arrayit Corporation Announces Allergy Testing Agreement with Sutter Health
2018年11月19日 - 7:30PM
Sunnyvale, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation
(OTC: ARYC), a life sciences and personalized medicine
company, announces an allergy testing agreement with Northern
California healthcare leader Sutter Health. The company is
providing its proprietary microarray-based finger stick allergy
testing services to Sutter Health via doctors in the Sutter
Health-affiliated Palo Alto Medical Foundation. Sutter Health, one
of the nation’s largest healthcare networks, is headquartered in
Sacramento California and has 50,000 employees including 12,000
physicians and 14,000 nurses serving 3 million Northern California
patients. Sutter Health draws 19% of its revenue from the
California Medical Assistance Program (Medi-Cal) and reports total
patient service revenues of $12,000,000,000 ($12 billion)
annually.
Arrayit recently completed an allergy testing pilot program for
a top retail chain, established a nationwide network of 1,700
allergy sales professionals, met with top officials at the United
States Food and Drug Administration (FDA) regarding approval of a
major product line, signed allergy testing contracts with a
consortium of 178 medical clinics, received approval for in-store
promotions by a major retailer, announced allergy testing
partnerships with major allergy therapeutics providers, received
approval for direct Medicare billing by the Centers for Medicare
and Medicaid Services (CMS), reported the sale and shipping of
clinical instrumentation to the FDA, aced three consecutive rounds
of proficiency testing with the College of American Pathologists,
launched the Patient Data Solutions allergy portal for doctors and
clinics, celebrated 25 years of company operations and announced
allergy test brands expansion. The agreement with Sutter Health
significantly expands the company’s allergy testing bandwidth to
include a major healthcare provider.
Chief Executive Officer Rene Schena states, “Partnering with
healthcare leader Sutter Health fits perfectly within our mission
of providing the most advanced allergy testing services available
to our diverse Northern California healthcare community. Sutter’s
focus on technological innovation, electronic medical records
advances and telemedicine are highly synergistic with our
physician-prescribed non-invasive finger stick microarray tests for
allergy and other health and wellness indications.”
About Arrayit
Arrayit Corporation, headquartered in Sunnyvale, California, leads
and empowers the research, biotechnology, pharmaceutical, clinical
and healthcare sectors through the discovery, development and
manufacture of proprietary life science and personalized medicine
products and services to advance biomedical research and improve
wellness and human health. Please
visit www.arrayit.com for more information.
Safe Harbor Statement
We have identified forward-looking statements by using words such
as "expect", "believe", and "should". Although we believe our
expectations are reasonable, our operations involve a number of
risks and uncertainties that are beyond our control, and these
statements may turn out not to be true. Risk factors associated
with our business, including some of the facts set forth herein,
are detailed in the Company's public filings.
CONTACT
Public Relations
Arrayit Corporation
Tel: 408-744-1331
Email: arrayit@arrayit.com
Web: www.arrayit.com
Public Relations
Arrayit Corporation
Tel: 408-744-1331
Email: arrayit@arrayit.com
Web: www.arrayit.com
Arrayit (CE) (USOTC:ARYC)
過去 株価チャート
から 10 2024 まで 11 2024
Arrayit (CE) (USOTC:ARYC)
過去 株価チャート
から 11 2023 まで 11 2024
